Patent US4737500A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4737500A Expired / Lapsed US ⏱️ 0.0 years remaining

1-substituted-4-(thiazolyl-2-)-piperazines, -piperidines and -tetrahydropyridines useful as anxiolytic, psychogeriatric, antidepressant and antischizophrenic agents

Assignee: Novartis Pharmaceuticals Corp
•
Filing: 1986-06-20
•
Granted: 1988-04-12
•
Expires: 2006-06-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Thiazoles or pharmaceutically acceptable acid addition salts thereof are useful as anxiolytic, psychogeriatric, antidepressant and antischizophrenic agents.

Inventors

  • 👤 Dieter Sorg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 09:52
CPC Classifications
C; C07; C07D; C07D417/00; C07D417/02; C07D417/12; C07D277/00; C07D277/02; C07D277/20; C07D277/32; C07D277/38; C07D277/42; C07D417/14; C07D471/00; C07D471/02; C07D471/04; C07D513/00; C07D513/02; C07D513/04

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 331 words
A compound of formula I: ##STR89## wherein R 1 and R 2 , independently, are hydrogen, (C 1-6 )alkyl, (C 3-6 )cycloalkyl, (C 3-6 )cycloalkyl(C 1-3 )alkyl, phenyl, phenyl(C 1-3 )alkyl, or R 1 and R 2 signify together trimethylene, tetramethylene or pentamethylene, optionally substituted at the same of different carbon atoms by 1 or 2 methyl groups, or R 1 and R 2 signify together --(CH 3 ) 2 C--O--C(CH 3 ) 2 --, R 1 may additionally signify trifluoromethyl; W is alkylene of 2 to 6 carbon atoms, or alkenylene or alkynylene of 4 to 6 carbon atoms, whereby the unsaturation is not adjacent to the nitrogen atoms; and R 3 is a group of formulae (a)-(n) ##STR90## m is 0 or 1, R 4 and R 4 ' independently are hydrogen or (C 1-4 )alkyl, R 5 and R 5 ' independently are hydrogen, (C 1-4 )alkyl, phenyl or phenyl(C 1-4 )alkyl, t is 4 or 5, R 6 is hydrogen or (C 1-3 )alkyl, and R 7 is hydrogen, (C 1-3 )alkyl, phenyl(C 1-3 )alkyl or phenoxy(C 1-3 )alkyl, or R 3 is a group of formula (o) ##STR91## in which R 8 is hydrogen or (C 1-3 )alkyl, R 9 is --COR 10 , --CON(R 11 )R 12 , --SO 2 R 10 or --SO 2 N(R 11 )R 12 , wherein R 10 is (C 1-6 )alkyl, (C 3-6 )cycloalkyl, phenyl or phenyl(C 1-3 )alkyl, wherein each phenyl is optionally mono- or independently di- or trisubstituted by (C 1-3 )alkyl, hydroxy, methoxy, methylenedioxy, amino, chloro, fluoro or trifluoromethyl, and R 11 and R 12 are each, independently, hydrogen or (C 1-3 )alkyl or R 11 and R 12 together signify tetramethylene or pentamethylene, provided that when W is dimethylene and R 9 is --COR 10 , wherein R 10 is 4-aminophenyl, at least one of R 1 , R 2 and R 8 is other than hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 331 words
A compound of formula I: ##STR89## wherein R 1 and R 2 , independently, are hydrogen, (C 1-6 )alkyl, (C 3-6 )cycloalkyl, (C 3-6 )cycloalkyl(C 1-3 )alkyl, phenyl, phenyl(C 1-3 )alkyl, or R 1 and R 2 signify together trimethylene, tetramethylene or pentamethylene, optionally substituted at the same of different carbon atoms by 1 or 2 methyl groups, or R 1 and R 2 signify together --(CH 3 ) 2 C--O--C(CH 3 ) 2 --, R 1 may additionally signify trifluoromethyl; W is alkylene of 2 to 6 carbon atoms, or alkenylene or alkynylene of 4 to 6 carbon atoms, whereby the unsaturation is not adjacent to the nitrogen atoms; and R 3 is a group of formulae (a)-(n) ##STR90## m is 0 or 1, R 4 and R 4 ' independently are hydrogen or (C 1-4 )alkyl, R 5 and R 5 ' independently are hydrogen, (C 1-4 )alkyl, phenyl or phenyl(C 1-4 )alkyl, t is 4 or 5, R 6 is hydrogen or (C 1-3 )alkyl, and R 7 is hydrogen, (C 1-3 )alkyl, phenyl(C 1-3 )alkyl or phenoxy(C 1-3 )alkyl, or R 3 is a group of formula (o) ##STR91## in which R 8 is hydrogen or (C 1-3 )alkyl, R 9 is --COR 10 , --CON(R 11 )R 12 , --SO 2 R 10 or --SO 2 N(R 11 )R 12 , wherein R 10 is (C 1-6 )alkyl, (C 3-6 )cycloalkyl, phenyl or phenyl(C 1-3 )alkyl, wherein each phenyl is optionally mono- or independently di- or trisubstituted by (C 1-3 )alkyl, hydroxy, methoxy, methylenedioxy, amino, chloro, fluoro or trifluoromethyl, and R 11 and R 12 are each, independently, hydrogen or (C 1-3 )alkyl or R 11 and R 12 together signify tetramethylene or pentamethylene, provided that when W is dimethylene and R 9 is --COR 10 , wherein R 10 is 4-aminophenyl, at least one of R 1 , R 2 and R 8 is other than hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 156 words
A compound according to claim 1 wherein R 1 and R 2 , independently, are hydrogen, (C 1-6 )alkyl, (C 3-6 )cycloalkyl, (C 3-6 )cycloalkyl(C 1-3 )alkyl, phenyl, phenyl(C 1-3 )alkyl, or R 1 and R 2 signify together trimethylene, tetramethylene or pentamethylene, optionally substituted at the same or different carbon atoms by 1 or 2 methyl groups, R 1 may additionally signify trifluoromethyl; W is alkylene of 2 to 6 carbon atoms; and R 3 is a group of formulae (a)-(n) in which ##STR92## m is 0 or 1, R 4 and R 4 ', independently, are hydrogen or (C 1-4 )alkyl, R 5 and R 5 ', independently, are hydrogen, (C 1-4 )alkyl, phenyl or phenyl(C 1-4 )alkyl, t is 4 or 5, R 6 is hydrogen or (C 1-3 )alkyl, and R 7 is hydrogen, (C 1-3 )alkyl, phenyl(C 1-3 )alkyl or phenoxy(C 1-3 )alkyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim 220 words
A compound according to claim 1 wherein R 1 and R 2 , independently, are hydrogen, (C 1-6 )alkyl, (C 3-6 )cycloalkyl, (C 3-6 )cycloalkyl(C 1-3 )alkyl, phenyl, phenyl(C 1-3 )alkyl, or R 1 and R 2 signify together trimethylene, tetramethylene or pentamethylene, optionally substituted at the same or different carbon atoms by 1 or 2 methyl groups, R 1 may additionally signify trifluoromethyl', W is alkylene of 2 to 6 carbon atoms; and R 3 is a group of formula (o) in which R 8 is hydrogen or (C 1-3 )alkyl, R 9 is --COR 10 , --CON(R 11 )R 12 , --SO 2 R 10 or --SO 2 N(R 11 )R 12 , wherein R 10 is (C 1-6 )alkyl, (C 3-6 )cycloalkyl, phenyl or phenyl(C 1-3 )alkyl, wherein each phenyl is optionally mono- or independently di- or trisubstituted by (C 1-3 )alkyl, hydroxy, methoxy, methylenedioxy, amino, chloro, fluoro or trifluoromethyl; and R 11 and R 12 are each, independently, hydrogen or (C 1-3 )alkyl or R 11 and R 12 together signify tetramethylene or pentamethylene, provided that when W is dimethylene and R 9 is --COR 10 , wherein R 10 is 4-aminophenyl, at least one of R 1 , R 2 and R 8 is other than hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
Claim 5
Dependent Claim 334 words
A compound according to claim 1 wherein R 1 and R 2 independently are hydrogen, (C 1-6 )alkyl, (C 3-6 )cycloalkyl, (C 3-6 )cycloalkyl(C 1-3 )alkyl, phenyl, phenyl(C 1-3 )alkyl, or R 1 and R 2 signify together pentamethylene, or R 1 and R 2 signify together --(CH 2 ) 2 C--O--C(CH 3 ) 2 --, R 1 is additionally trifluoromethyl; W is alkylene of 2 to 6 carbon atoms, or alkenylene or alkynylene of 4 to 6 carbon atoms, whereby the unsaturation is not adjacent to the nitrogen atoms, and R 3 is a group of formula (a) in which A is CH 2 , B is CO, m is 1, R 4 ' and R 5 ' are each hydrogen, and R 4 and R 5 are each methyl, or a group of formula (a) in which A is CH 2 , B is CH 2 , m is 0 and R 4 and R 5 are each hydrogen, or R 3 is a group of formula (b), in which t is 4; or R 3 is a group of formula (f), in which B is CO; or R 3 is a group of formula (g), in which A is NH; or R 3 is a group of formula (i), in which E is N; or R 3 is a group of formula (j), in which A' is CH 2 and B is CO; or R 3 is a group of formula (o), in which R 8 is hydrogen or (C 1-3 )alkyl, R 9 is --COR 10 or --SO 2 R 10 , wherein R 10 is (C 1-6 )alkyl or phenyl, wherein phenyl is optionally mono- or independently di- or trisubstituted by hydroxy, methoxy, amino, chloro or fluoro, provided that when W is dimethylene and R 9 is --COR 10 , wherein R 10 is 4-aminophenyl, at least one of R 1 , R 2 and R 8 is other than hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Dependent Claim 16 words
A compound of claim 1 which is 4,4-dimethyl-1-(4-(4-(4-(1,1-dimethylethyl)-2-thiazolyl)-1-piperazinyl)butyl)-2,6-piperidin-dione or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Dependent Claim 16 words
A compound of claim 1 which is 5-chloro-2-methoxy-N-(2-(4-(4-(1,1-dimethylethyl)-2-thiazolyl)-1-piperazinyl)ethyl)benzamide or a pharmaceutically acceptable acid addition salt thereof.
Claim 8
Dependent Claim 38 words
A pharmaceutical composition useful in treating anxiety, geriatric disorders, depressions or schizophrenia comprising a pharmaceutically acceptable carrier or diluent and a therapeutically effective amount of a compound of claim 1, or a pharmaceutically acceptable acid addition salt thereof.
Claim 9
Dependent Claim 61 words
A compound of claim 1 wherein R 1 is trifluoromethyl, R 2 is hydrogen, W is --CH 2 -- 4 and R 3 is a group of formula (a) in which A is CH 2 , B is CH 2 , m is 0 and R 4 and R 5 are each hydrogen, or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim 40 words
A method of effecting anxiolytic or psychogeriatric treatment in a subject in need of such treatment, which method comprises administering to said subject an effective amount of a compound of claim 1 or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim 38 words
A method of effecting antischizophrenic treatment in a subject in need of such treatment, which method comprises administering to said subject an effective amount of a compound of claim 1 or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim 38 words
A method of effecting antidepressant treatment in a subject in need of such treatment, which method comprises administering to said subject an effective amount of a compound of claim 1 or a pharmaceutically acceptable acid addition salt thereof.

References Cited (Backward Citations)

US3331843A Cited
US3489757A Cited
US3717634A Cited
NL7204539A Cited
US3822267A Cited
US4064244A Cited
US4182763A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-04-12 1991-10-12 1992-04-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-04-12 1995-10-12 1996-04-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-04-12 1999-10-12 2000-04-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag